An integrated national scale SARS-CoV-2 genomic surveillance network.

The COVID-19 Genomics UK (COG-UK) consortium, , Smith, Darren and Bashton, Matthew (2020) An integrated national scale SARS-CoV-2 genomic surveillance network. The Lancet Microbe, 3 (1). E99-E100. ISSN 2666-5247

Preview	Text PIIS2666524720300549.pdf - Published Version Available under License Creative Commons Attribution 4.0. Download (45kB) | Preview
Preview	Text (Supplementary appendix) 1-s2.0-S2666524720300549-mmc1.pdf - Supplemental Material Download (193kB) | Preview
Preview	Text (Corrected Proof) PIIS2666524720300549.pdf - Other Available under License Creative Commons Attribution 4.0. Download (46kB) | Preview

Abstract

The Coronavirus Disease 2019 (COVID-19) Genomics UK Consortium (COG-UK) was launched in March, 2020, with £20 million support from UK Research and Innovation, the UK Department of Health and Social Care, and Wellcome Trust. The goal of this consortium is to sequence severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for up to 230 000 patients, health-care workers, and other essential workers in the UK with COVID-19, which will help to enable the tracking of SARS-CoV-2 transmission, identify viral mutations, and integrate with health data to assess how the viral genome interacts with cofactors and consequences of COVID-19.

Actions (login required)

View Item

Downloads